Embedding learning in FDA’s DNA

To keep pace with rapidly advancing science, integrate patient perspectives into regulatory decisions, and learn from mistakes, medical product regulators must embed external engagement and continuous learning into their core operations.

FDA leaders have long recognized the value of outside perspectives, and of identifying and disseminating best practices. Yet efforts to harness them have been sporadic, underpowered, and insufficiently institutionalized...